GlassScriptPhysician profile
Jennifer Briner
NPI 1649092834
$1,145.54
in general payments reported to CMS, 2019-2025
20 companies · $1,146 in 2025
The $1,146 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $265.30 | 2025 | |
| Novo Nordisk INC | $105.11 | 2025 | Ozempic, Rybelsus, Wegovy |
| Corcept Therapeutics | $100.91 | 2025 | Korlym |
| Glaxosmithkline, LLC. | $90.96 | 2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Kowa Pharmaceuticals America, INC. | $86.07 | 2025 | Zoryve |
| Astrazeneca Pharmaceuticals LP | $83.81 | 2025 | Farxiga, Airsupra |
| Lilly USA, LLC | $64.21 | 2025 | Mounjaro |
| Abbvie INC. | $58.59 | 2025 | |
| Tolmar, INC. | $46.36 | 2025 | Jatenzo |
| Exact Sciences Corporation | $34.44 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Inspire Medical Systems, INC. | $34.03 | 2025 | Inspire |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.03 | 2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $22.59 | 2025 | |
| Ardelyx, INC. | $21.91 | 2025 | Ibsrela |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.44 | 2025 | Caplyta |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.25 | 2025 | Jardiance |
| Pfizer INC. | $16.40 | 2025 | |
| Medtronic, INC. | $15.85 | 2025 | Inceptiv |
| Merck Sharp & Dohme LLC | $14.28 | 2025 | Capvaxive, Gardasil 9 |
| Phathom Pharmaceuticals, INC. | $12.00 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Briner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.